Literature DB >> 19559774

Alteration of transcriptional profile in human bronchial epithelial cells induced by cigarette smoke condensate.

Ying-Chun Hu1, Zhi-Hua Yang, Ke-Jun Zhong, Li-Jing Niu, Xiu-Jie Pan, De-Chang Wu, Xian-Jun Sun, Ping-Kun Zhou, Mao-Xiang Zhu, Yan-Ying Huo.   

Abstract

Despite the significance of cigarette smoke for carcinogenesis, the molecular mechanisms that lead to increased susceptibility of human cancers are not well-understood. In our present study, the oncogenic transforming effects of cigarette smoke condensate (CSC) were examined using papillomavirus-immortalized human bronchial epithelial cells (BEP2D). Growth kinetics, saturation density, resistance to serum-induced terminal differentiation, anchorage-independent growth and tumorigenicity in nude mice were used to investigate the various stages of transformation in BEP2D cells. Illumina microarray platforms were used to explore the CSC-induced alteration of global mRNA expression profiles of the earlier period and the advanced stage of CSC-treated BEP2D cells. We showed here that a series of sequential steps arose among CSC-treated immortalized human bronchial epithelial cells, including altered growth kinetics, resistance to serum-induced terminal differentiation, and anchorage-independence growth. In the earlier period of CSC treatment, 265 genes were down-regulated and 63 genes were up-regulated, respectively, and in the advanced stage of CSC treatment, 313 genes were down-regulated and 145 genes were up-regulated, respectively. Notably, among those genes, the expression of some of imprinted genes such as IGF2, NDN, H19 and MEG3 were all silenced or down-regulated in CSC-treated cells. These genes reactivated after 5 microM 5-aza-2-deoxycytidine (5-aza-dC) treatment. These results demonstrated that long-term treatment of human bronchial epithelial cells with CSC may adversely affect their genetic and epigenetic integrity and lead to further transformation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19559774     DOI: 10.1016/j.toxlet.2009.06.860

Source DB:  PubMed          Journal:  Toxicol Lett        ISSN: 0378-4274            Impact factor:   4.372


  6 in total

1.  Genome-wide methylation profiling and the PI3K-AKT pathway analysis associated with smoking in urothelial cell carcinoma.

Authors:  Mariana Brait; Enrico Munari; Cynthia LeBron; Maartje G Noordhuis; Shahnaz Begum; Christina Michailidi; Nilda Gonzalez-Roibon; Leonel Maldonado; Tanusree Sen; Rafael Guerrero-Preston; Leslie Cope; Paola Parrella; Vito Michele Fazio; Patrick K Ha; George J Netto; David Sidransky; Mohammad O Hoque
Journal:  Cell Cycle       Date:  2013-02-22       Impact factor: 4.534

2.  MiR-148a regulates MEG3 in gastric cancer by targeting DNA methyltransferase 1.

Authors:  Jiang Yan; Xiaoqiang Guo; Jiazeng Xia; Tin Shan; Chen Gu; Zheng Liang; Wei Zhao; Shimao Jin
Journal:  Med Oncol       Date:  2014-02-11       Impact factor: 3.064

3.  Chemical exposure as etiology in developmental origin of adult onset human cancer.

Authors:  Kirsi Vähäkangas
Journal:  Front Pharmacol       Date:  2011-12-16       Impact factor: 5.810

4.  Identification of DNA methylation changes in newborns related to maternal smoking during pregnancy.

Authors:  Christina A Markunas; Zongli Xu; Sophia Harlid; Paul A Wade; Rolv T Lie; Jack A Taylor; Allen J Wilcox
Journal:  Environ Health Perspect       Date:  2014-06-06       Impact factor: 9.031

5.  In utero exposures to environmental organic pollutants disrupt epigenetic marks linked to fetoplacental development.

Authors:  Maya A Kappil; Qian Li; An Li; Priyanthi S Dassanayake; Yulin Xia; Jessica A Nanes; Philip J Landrigan; Christopher J Stodgell; Kjersti M Aagaard; Eric E Schadt; Nancy Dole; Michael Varner; John Moye; Carol Kasten; Richard K Miller; Yula Ma; Jia Chen; Luca Lambertini
Journal:  Environ Epigenet       Date:  2016-02-10

Review 6.  Long non-coding RNAs in non-small cell lung cancer: functions and distinctions from other malignancies.

Authors:  Maolong Wang; Xiao Sun; Hao Wang; Yanlu Xin; Wenjie Jiao
Journal:  Transl Cancer Res       Date:  2019-11       Impact factor: 1.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.